Financhill
Back

Givaudan SA Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Sell
43

GVDNY
Givaudan SA

Last Price:
$68.24
Seasonality Move:
4.84%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Sell
43
Givaudan SA (GVDNY) is a Sell

Is Givaudan SA a Buy, Sell or Hold?

  • The current Givaudan SA [GVDNY] share price is $68.24. The Score for GVDNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • GVDNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GVDNY Stock Price Chart

What is Givaudan SA's stock price today?

  • The Givaudan SA share price today is $68.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GVDNY is experiencing slight buying pressure.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

GVDNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.33 Sell
Relative Strength Index (14 RSI): 38 Sell
Chaikin Money Flow: 81940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.09 - 74.73) Sell
Bollinger Bands (100): (73.05 - 83.01) Sell

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

GVDNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.15 Buy
20-day SMA: 69.42 Sell
50-day SMA: 75.05 Sell
200-day SMA: 82.77 Sell
8-day EMA: 67.88 Buy
20-day EMA: 69.73 Sell
50-day EMA: 73.56 Sell
200-day EMA: 81.19 Sell

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

Givaudan SA Earnings Growth & GVDNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

Givaudan SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):